News
Hosted on MSN1mon
Pediatrix Medical Group outlines $215M-$235M adjusted EBITDA target for 2025 amid portfolio restructuring benefitsEarnings Call Insights: Pediatrix Medical Group (NYSE:MD ... EBITDA guidance of $215 million to $235 million, reflecting benefits from portfolio restructuring and a focus on operational stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback